
AI-designed viruses: vast promise, guarded progress
AI can design novel viruses with potential to accelerate vaccines and therapies, but poses misuse risks; the Washington Post Editorial Board argues for handling the risk through stronger physical infrastructure and lab screening standards for gene synthesis, not censorship, pointing to a bipartisan Senate measure attached to the NDAA to help prevent abuse while preserving innovation.
